Zahn becomes director of ped card at Cedars

| | Health Imaging | Artificial Intelligence
pediatric cardiology - 272.44 Kb
Evan M. Zahn, MD Source: Cedars-Sinai Heart Institute
Evan M. Zahn, MD, has joined the Cedars-Sinai Heart Institute in Los Angeles to focus on the study of congenital heart disease and develop more minimally invasive treatments for the program. As director of pediatric cardiology at the Cedars-Sinai Heart Institute and director of its congenital heart disease program, he will diagnose and treat children born with heart defects such as hypoplastic left heart syndrome and tetralogy of Fallot.

Zahn also will be establishing a program aimed at treating adult patients with congenital heart issues.   

He joined Cedars-Sinai after serving as chief of cardiology at Miami Children's Hospital. Zahn also directed Miami Children’s interventional catheterization program and performed the world’s first nonsurgical tricuspid valve replacement via catheter on a 9-year-old boy. 

Zahn received a bachelor’s degree in biology at the State University of New York at Albany before earning his medical degree from New York Medical College in Valhalla. He completed his pediatric training at the University of Colorado’s Affiliated Hospitals in Denver. 

Related Content

Most popular radiology video interviews on Health Imaging
RamSoft and Alpha Nodus partner to streamline imaging prior authorization processes
GE HealthCare launches new AI-enabled automated breast ultrasound system
AI quantifies breast arterial calcifications on mammograms
AI 'not safe' to be implemented as a solo reader for breast cancer screening exams
What radiologists think about using ChatGPT and AI in breast imaging

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.